PROPRIETARY TECHNOLOGY
PrismCore™ Multi-Wavelength Technology
The only retinal laser integrating four wavelengths into a single console. Complete versatility. Streamlined workflow. One powerful platform.
The PrismCore™ Advantage
Four clinically proven wavelengths in one integrated system.
The most effective wavelengths for laser treatment are those with optimal tissue absorption properties for the target condition. PrismCore™ combines 532nm, 577nm, 670nm, and 810nm wavelengths into a single console, allowing physicians to select the ideal wavelength for each clinical indication.
Traditional retinal laser systems limit physicians to a single wavelength, forcing clinics to purchase multiple devices. PrismCore™ eliminates this limitation, delivering comprehensive wavelength coverage from one platform with no compromise in performance. Every wavelength is paired with SP-Mode® Microsecond Laser Technology for sub-threshold treatment options across all clinical indications.
Clinical Flexibility with Every Wavelength
Each wavelength is optimized for specific tissue absorption properties, giving physicians the ability to tailor treatments with precision.
532nm Green
The Gold Standard
Highly absorbed by melanin and hemoglobin.
- Panretinal photocoagulation
- Diabetic retinopathy
- Central/branch retinal vein occlusion
- Retinal tears, holes & detachments
- Endophotocoagulation
- Laser trabeculoplasty
- SP-Mode® laser trabeculoplasty
577nm Yellow
Macular Precision
Highly absorbed by melanin with peak absorption in oxyhemoglobin, negligible xanthophyll absorption, and low light scattering.
- Diabetic macular edema (focal photocoagulation)
- Macular treatments
- Abnormal vasculature
- Panretinal photocoagulation
- Diabetic retinopathy
- Central/branch retinal vein occlusion
- Retinal tears, holes & detachments
- Endophotocoagulation
- SP-Mode® macular laser (DME, CSCR)
- Laser trabeculoplasty
- SP-Mode® laser trabeculoplasty
670nm Red
The Ideal Choice When Opacities Are Present
Well absorbed by melanin, minimally absorbed by hemoglobin, negligible xanthophyll absorption. Good penetration through media hemorrhage, opacity, and sclera.
- Panretinal photocoagulation
- Diabetic retinopathy
- Central/branch retinal vein occlusion
- Retinal tears, holes & detachments
- Endophotocoagulation
- SP-Mode® macular laser (DME, CSCR)
810nm Infrared
The Versatile Alternative for Deep Penetration
Well absorbed by melanin, deep choroidal reach, minimal lens absorption, no flash light. Good penetration through media hemorrhage and sclera.
- Panretinal photocoagulation
- Diabetic retinopathy
- Central/branch retinal vein occlusion
- Retinal tears, holes & detachments
- Endophotocoagulation
- Retinopathy of prematurity
- SP-Mode® macular laser (DME, CSCR)
- Transscleral cyclophotocoagulation (TSCPC)
- SP-Mode® TSCPC
- SP-Mode® laser trabeculoplasty
- Transpupillary thermotherapy (choroidal tumor)
Key Advantages
One platform replaces multiple standalone lasers, expanding capability while simplifying your practice.
Streamlined Workflow
Switch wavelengths without changing systems. Faster treatment delivery, reduced physician fatigue, and greater patient comfort.
Scalable Configuration
Start with one or two wavelengths and add more as your practice needs evolve. The modular design lets you expand capability without replacing your system.
Smaller Footprint
Consolidate four laser technologies into one console, freeing up valuable clinic space and simplifying equipment management.
Ultra-Fast Pattern Scanning
Galvanometer-based pattern scanning with parfocal continuously variable zoom from 50 to 500 micrometers for shorter treatment sessions and higher throughput.
Backed by Science
Peer-reviewed publications supporting multi-wavelength laser applications in ophthalmology.
Subthreshold Laser Therapy for Central Serous Chorioretinopathy
Madani R, Ayoub A, Alasil T, Retina Today, 2024
Read Paper →Kikushima W, Furuhata Y, Shijo T, et al., Photodiagnosis and Photodynamic Therapy, 2025
Read Paper →Kikushima W, Shijo T, Furuhata Y, et al., Pharmaceuticals, 2021
Read Paper →Marashi A, Zazo A, Annals of Medicine and Surgery, 2022
Read Paper →Short-Term Outcome (1 Year) of Yellow Subthreshold Pulsed Laser Treatment on Diabetic Macular Edema
Kikushima W, Tateno Y, Furuhata Y, Shijo T, 36th Annual Meeting, Japanese Society for Ocular Circulation, 2019
Read Paper →Green Subthreshold Laser for Central Serous Chorioretinopathy
Khatri A, Pradhan E, Singh S, et al., Clinical Ophthalmology, 2018
Read Paper →Akpolat C, Evliyaoglu F, Kurt MM, et al., Clinical J Ophthalmol, 2018
Read Paper →Sub-Threshold Micropulse Yellow 577 Laser for Retinal Diseases
Remesnikov, Astana Vision, Kazakhstan, 2017
Read Paper →Available on These Systems
PrismCore™ powers LIGHTMED's multi-wavelength laser platform.
